153 related articles for article (PubMed ID: 16586107)
1. Expression of Helicobacter pylori cag12 gene in Lactococcus lactis MG1363 and its oral administration to induce systemic anti-Cag12 immune response in mice.
Kim SJ; Jun DY; Yang CH; Kim YH
Appl Microbiol Biotechnol; 2006 Sep; 72(3):462-70. PubMed ID: 16586107
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of Lactococcus lactis expressing Helicobacter pylori Cag7-ct383 protein induces systemic anti-Cag7 immune response in mice.
Kim SJ; Lee JY; Jun DY; Song JY; Lee WK; Cho MJ; Kim YH
FEMS Immunol Med Microbiol; 2009 Dec; 57(3):257-68. PubMed ID: 19807786
[TBL] [Abstract][Full Text] [Related]
3. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.
Lee MH; Roussel Y; Wilks M; Tabaqchali S
Vaccine; 2001 Jul; 19(28-29):3927-35. PubMed ID: 11427267
[TBL] [Abstract][Full Text] [Related]
4. Optimized expression of Helicobacter pylori ureB gene in the Lactococcus lactis nisin-controlled gene expression (NICE) system and experimental study of its immunoreactivity.
Zhang XJ; Duan G; Zhang R; Fan Q
Curr Microbiol; 2009 Apr; 58(4):308-14. PubMed ID: 19238485
[TBL] [Abstract][Full Text] [Related]
5. Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development.
Zhang R; Duan G; Shi Q; Chen S; Fan Q; Sun N; Xi Y
Biotechnol Lett; 2016 Nov; 38(11):1911-1916. PubMed ID: 27406731
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
7. Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice.
Zhang R; Wang C; Cheng W; Duan G; Shi Q; Chen S; Fan Q
Biotechnol Lett; 2018 Mar; 40(3):585-590. PubMed ID: 29299716
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
[TBL] [Abstract][Full Text] [Related]
9. [Expression of helicobacter pylori alpA gene in lactococcus lactis and its immunogenicity analysis].
Sun ZL; Bi YW; Bai CM; Gao DD; Li ZH; Dai ZX; Li JF; Xu WM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):203-6. PubMed ID: 20230679
[TBL] [Abstract][Full Text] [Related]
10. Food-grade expression of Helicobacter pylori ureB subunit in Lactococcus lactis and its immunoreactivity.
Chen S; Zhang R; Duan G; Shi J
Curr Microbiol; 2011 Jun; 62(6):1726-31. PubMed ID: 21431835
[TBL] [Abstract][Full Text] [Related]
11. An engineered Lactococcus lactis strain exerts significant immune responses through efficient expression and delivery of Helicobacter pylori Lpp20 antigen.
Zhang R; Peng X; Duan G; Shi Q; Chen S; Wang C; Fan Q; Xi Y
Biotechnol Lett; 2016 Dec; 38(12):2169-2175. PubMed ID: 27646988
[TBL] [Abstract][Full Text] [Related]
12. Lactococcus-based vaccine against brucellosis: IgG immune response in mice with rOmp16-IL2 fusion protein.
Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
Arch Microbiol; 2021 Jul; 203(5):2591-2596. PubMed ID: 33689001
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant.
Vasquez AE; Manzo RA; Soto DA; Barrientos MJ; Maldonado AE; Mosqueira M; Avila A; Touma J; Bruce E; Harris PR; Venegas A
Hum Vaccin Immunother; 2015; 11(3):776-88. PubMed ID: 25750999
[TBL] [Abstract][Full Text] [Related]
15. A study of recombinant protective H.pylori antigens.
Jiang Z; Tao XH; Huang AL; Wang PL
World J Gastroenterol; 2002 Apr; 8(2):308-11. PubMed ID: 11925614
[TBL] [Abstract][Full Text] [Related]
16. Production of
Rezaei M; Rabbani Khorasgani M; Zarkesh Esfahani SH; Emamzadeh R; Abtahi H
Can J Microbiol; 2020 Jan; 66(1):39-45. PubMed ID: 31574230
[TBL] [Abstract][Full Text] [Related]
17. Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration.
Yagnik B; Sharma D; Padh H; Desai P
J Appl Microbiol; 2017 Feb; 122(2):493-505. PubMed ID: 27860045
[TBL] [Abstract][Full Text] [Related]
18. Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice.
Aliramaei MR; Khorasgani MR; Rahmani MR; Zarkesh Esfahani SH; Emamzadeh R
Microb Pathog; 2019 Dec; 142():103926. PubMed ID: 31838174
[TBL] [Abstract][Full Text] [Related]
19. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
Ahmed B; Loos M; Vanrompay D; Cox E
Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
